Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia

• Catherine C. Coombs,
• David A. Sallman,
• Sean M. Devlin,
• Shweta Dixit,
• Abhinita Mohanty,
• Kristina Knapp,
• Najla H. Al Ali,
• Jeffrey E. Lancet,
• Alan F. List,
• Rami S. Komrokji,
• Eric Padron,
• Maria E. Arcila,
• Virginia M. Klimek,
• Marcel R. M. van den Brink,
• Martin S. Tallman,
• Ross L. Levine,
• Raajit K. Rampal,
• Franck Rapaport

Affiliations

Catherine C. Coombs

Memorial Sloan Kettering Cancer Center, Department of Medicine, Leukemia Service, New York, NY, USA

David A. Sallman

H. Lee Moffitt Cancer Center and Research Institute, Department of Malignant Hematology, Tampa, FL, USA

Sean M. Devlin

Memorial Sloan Kettering Cancer Center, Department of Epidemiology & Biostatistics, New York, NY, USA

Shweta Dixit

Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, NY, USA

Abhinita Mohanty

Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, NY, USA

Kristina Knapp

Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, NY, USA

Najla H. Al Ali

H. Lee Moffitt Cancer Center and Research Institute, Department of Malignant Hematology, Tampa, FL, USA

Jeffrey E. Lancet

H. Lee Moffitt Cancer Center and Research Institute, Department of Malignant Hematology, Tampa, FL, USA

Alan F. List

H. Lee Moffitt Cancer Center and Research Institute, Department of Malignant Hematology, Tampa, FL, USA

Rami S. Komrokji

H. Lee Moffitt Cancer Center and Research Institute, Department of Malignant Hematology, Tampa, FL, USA

Eric Padron

H. Lee Moffitt Cancer Center and Research Institute, Department of Malignant Hematology, Tampa, FL, USA

Maria E. Arcila

Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, NY, USA

Virginia M. Klimek

Memorial Sloan Kettering Cancer Center, Department of Medicine, Leukemia Service, New York, NY, USA

Marcel R. M. van den Brink

Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY, USA

Martin S. Tallman

Memorial Sloan Kettering Cancer Center, Department of Medicine, Leukemia Service, New York, NY, USA;Weill Cornell Medical College, New York, NY, USA

Ross L. Levine

Memorial Sloan Kettering Cancer Center, Department of Medicine, Leukemia Service, New York, NY, USA;Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, NY, USA

Raajit K. Rampal

Memorial Sloan Kettering Cancer Center, Department of Medicine, Leukemia Service, New York, NY, USA

Franck Rapaport

Memorial Sloan Kettering Cancer Center, Department of Medicine, Leukemia Service, New York, NY, USA